Zeltiq Aesthetics Inc. (ZLTQ) Shares Up 2.1%
Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) shot up 2.1% on Monday . The company traded as high as $37.75 and last traded at $37.55, with a volume of 225,275 shares traded. The stock had previously closed at $36.79.
A number of research firms have recently weighed in on ZLTQ. Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $40.00 target price on shares of Zeltiq Aesthetics in a research report on Monday, May 2nd. Zacks Investment Research downgraded shares of Zeltiq Aesthetics from a “hold” rating to a “sell” rating in a research report on Thursday, July 14th. Brean Capital reaffirmed a “buy” rating on shares of Zeltiq Aesthetics in a research report on Thursday, April 28th. TheStreet downgraded shares of Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a research report on Friday, June 10th. Finally, Leerink Swann reaffirmed an “outperform” rating and issued a $48.00 target price (up from $43.00) on shares of Zeltiq Aesthetics in a research report on Thursday, August 11th. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $38.33.
The company has a market cap of $1.49 billion and a price-to-earnings ratio of 56.69. The stock’s 50-day moving average is $33.29 and its 200-day moving average is $27.86.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last released its earnings results on Monday, August 8th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.07. The firm earned $89.50 million during the quarter, compared to analyst estimates of $79.68 million. During the same period last year, the business posted $0.03 EPS. The company’s revenue was up 38.9% on a year-over-year basis. On average, equities analysts forecast that Zeltiq Aesthetics Inc. will post ($0.13) earnings per share for the current fiscal year.
In related news, VP Bradley Hauser sold 3,000 shares of Zeltiq Aesthetics stock in a transaction dated Monday, July 11th. The stock was sold at an average price of $30.02, for a total value of $90,060.00. Following the completion of the sale, the vice president now directly owns 47,184 shares in the company, valued at $1,416,463.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mark J. Foley sold 10,000 shares of Zeltiq Aesthetics stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $37.26, for a total value of $372,600.00. Following the completion of the sale, the insider now owns 311,274 shares of the company’s stock, valued at $11,598,069.24. The disclosure for this sale can be found here.
An institutional investor recently bought a new position in Zeltiq Aesthetics stock. Trexquant Investment LP acquired a new stake in shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 57,500 shares of the company’s stock, valued at approximately $1,640,000. Trexquant Investment LP owned approximately 0.15% of Zeltiq Aesthetics as of its most recent filing with the SEC.
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.